ICP Parking Lot/Vaccines: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{TOCright}}
{{TOCright}}
= [[Vaccines/Glossary|Research Vocabulary]] =
=Talks=
=Structured Rational for the Paper=
* [[Vaccines/Sara Crager on Vaccines]]
# [[Vaccines/The_Argument_Framework|The Argument Framework]]
=Vaccines/Bibliography|Bibliography=
=Study of the field=
* 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
Analysis of the field with basis on [https://cyber.law.harvard.edu/commonsbasedresearch/Field_Research_Methodology Field Research Methodology]
* Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at:  www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
# [[Overview of Economics of Intellectual Property in Vaccines]]
*  Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
# [[Give an overall picture of the Vaccines' sector]]
* LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
# Outputs and Products of the field: [[data, narratives and tools produced by the Vaccines' sector]]
* Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
# Legal tools available for and in use by the actors of Vaccines' sector: [[IP in Vaccines]]
* University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
# [[competitive advantages in Vaccines]]
* The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
# [[IP Profile of Biggest for-profit companies in Vaccines]]
* New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
# [[IP Profile of non-profit companies in Vaccines]]
* Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
# [[IP Profile of Universities working in Vaccines]]
* Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
# [[IP Profile of Associations in Vaccines]]
* Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
# [[Commons based cases in Vaccines]]
* Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
# [[Peer-Production Business models in Vaccines]]
* Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
# [[Open Business models in Vaccines]]
* Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott
=[[Vaccines/Bibliography|Bibliography]]=
 
*'''American Society of Law, Medicine & Ethics, Inc., and Boston University American Journal of Law & Medicine, 2009, 35 Am. J. L. and Med.:'''
** [[Vaccines/Bibliography|Highlights]]
*'''Follow-On Biologics: Intellectual Property and Innovation Issues'''
introduces innovation policy issues pertaining to follow-on biologics. @http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf  
*'''Emerging Health Care Issues: Follow-on Biologic Drug Competition'''
@www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
=Navigation=
=Navigation=
Back to [[Main Page]]
Back to [[ICP Parking Lot]]<br>
Back to [[Biotechnology_-_Genomic_and_Proteomics]]
Back to [[Biotechnology_-_Genomic_and_Proteomics]]<br>
Back to [[Main Page]]<br>

Latest revision as of 20:12, 5 May 2010

Talks

Vaccines/Bibliography|Bibliography

  • 'Follow-On Biologics: Intellectual Property and Innovation Issues (2009) Available at: http://www.bio.org/healthcare/followon/ and @www.biosimilars.com/CRS_FOBs.pdf
  • Emerging Health Care Issues: Follow-on Biologic Drug Competition. (2009) Available at: www.ftc.gov/os/2009/06/P083901biologicsreport.pdf
  • Intellectual Property Watch, 2010. Biotech Marathon: Vaccines And Open Innovation, But Less IP? Available at: http://www.ip-watch.org/weblog/2010/02/16/biotech-marathon-vaccines-and-open-innovation-but-less-ip/.
  • LUDWIG,STEVEN R. (2009) Data Exclusivity – A Necessary Form of Intellectual Property. Available at: www.iptoday.com/pdf/2007/8/Ludwig-Aug2007.pdf
  • Will HPV Vaccines Prevent Cervical Cancers Among Poor Women of Color?: Global Health Policy at the Intersection of Human Rights and Intellectual Property Law, Kevin Outterson. 2009, 35 Am. J. L. and Med.
  • University Contributions to the HPV Vaccine and Implications for Access to Vaccines in Developing Countries: Addressing Materials and Know-How in University Technology Transfer Policy, Sara E. Crager, Ethan Guillen, & Matt Price. 2009, 35 Am. J. L. and Med.
  • The Global Health Licensing Program: A New Model for Humanitarian Licensing at the University Level, Beirne Roose-Snyder & Megan K. Doyle. 2009, 35 Am. J. L. and Med.
  • New Vaccines for Developing Countries: Will it be Feast or Famine?, Jon Kim Andrus, MD, + Ciro de Quadros, MD, MPH, Cuauhtemoc Ruiz Matus, MD, MPH, Silvana Luciani MHSc, & Peter Hotez, MD, PhD. 2009, 35 Am. J. L. and Med.
  • Compulsory Licenses: A Tool to Improve Global Access to the HPV Vaccine?, Peter Maybardule & Sarah Rimmingto. 2009, 35 Am. J. L. and Med.
  • Clinical Preventive Services for Adolescents: Position Paper of the Society for Adolescent Medicine, Abigail English, Carol A. Ford, & John S. Santelli. 2009, 35 Am. J. L. and Med.
  • Human Rights In Health Equity: Cervical Cancer and HPV Vaccines, Joanna N. Erdman. 2009, 35 Am. J. L. and Med.
  • Potential Barriers to HPV Immunization: From Public Health to Personal Choice, Gregory D. Zimet. 2009, 35 Am. J. L. and Med.
  • Overcoming Barriers and Ensuring Access to HPV Vaccines in Low-Income Countries, Vivien Davis Tsu. 2009, 35 Am. J. L. and Med.
  • Addressing Supply Side Barriers to Introduction of New Vaccines to the Developing World, Sean McElligott

Navigation

Back to ICP Parking Lot
Back to Biotechnology_-_Genomic_and_Proteomics
Back to Main Page

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=ICP_Parking_Lot/Vaccines&oldid=7210"